Position in VNRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$8,110
+$2,767 QoQ
Shares Held
2,028
+97.3% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VNRX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $230,407,971 across 39 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
181,223 | $57,056,249 | |
| 2 | ABT |
Abbott Laboratories
|
619,756 | $56,236,659 | |
| 3 | MDT |
Medtronic plc
|
618,387 | $48,376,415 | |
| 4 | BSX |
Boston Scientific Corp
|
462,281 | $19,730,153 | |
| 5 | EW |
Edwards Lifesciences Corp
|
105,195 | $9,515,939 | |
| 6 | DXCM |
Dexcom Inc
|
126,816 | $8,541,057 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
79,315 | $5,076,953 | |
| 8 | GMED |
Globus Medical Inc
|
51,719 | $4,086,318 |
All Filings in VNRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,110 | 40,550 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $5,343 | 20,550 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,634 | 20,050 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||